RZLT ▼ -1.2% - Rezolute, Inc.
$RZLT - Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
05-OCT-2026 07:00 AM ET
Share this post
More filings for $RZLT
RZLT - Rezolute, Inc. - SEC Filing Update (13-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 13, 2026RZLT - Rezolute, Inc. - SEC Filing Update (13-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 13, 2026RZLT ▲ +10.1% - Rezolute, Inc.Nov 13, 2026RZLT ▲ +10.1% - Rezolute, Inc.Nov 13, 2026RZLT ▼ -8.1% - Rezolute, Inc.Nov 5, 2026RZLT ▼ -0.8% - Rezolute, Inc.Nov 2, 2026
View full $RZLT filing history →💬 Comments
Loading comments…
Leave a comment